ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation.
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2016
At a glance
- Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
- Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic nephropathies; Diabetic retinopathy; Hypertension; Proteinuria; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms ADVANCE
- Sponsors Servier
- 31 Aug 2018 Biomarkers information updated
- 01 Sep 2016 Results of post-hoc analysis (n=11140) published in the Diabetologia (2016).
- 03 Aug 2012 Additional lead trial investigator and centre added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History